Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...
Teradyne Inc . (NASDAQ:TER), with its substantial market capitalization of $18.71 billion, has emerged as a key player in the burgeoning artificial intelligence (AI) and semiconductor testing markets, ...
On Monday, Nvidia, the largest company in the U.S., lost 17%—a record $600 billion in market capitalization—as investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback